Mallinckrodt

mallinckrodt.com

Total trials

90

Active

0

Phase 3

30

Total enrollment

10,032

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Healthy8
  • Pain7
  • Fever5
  • Acute Pain4
  • Lung Disease3
  • Hepatorenal Syndrome3
  • Amyotrophic Lateral Sclerosis2
  • Chronic Pain2

Frequently asked questions about Mallinckrodt

How many clinical trials does Mallinckrodt have on ClinicalTrials.gov?
Mallinckrodt is listed as the lead sponsor on 90 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
How many of Mallinckrodt's trials are in Phase 3?
30 of Mallinckrodt's trials are in Phase 3.
What therapeutic areas does Mallinckrodt focus on?
Mallinckrodt's most-studied conditions on ClinicalTrials.gov are Healthy, Pain, Fever, Acute Pain, Lung Disease.